This ANDA has been found to be bioequivalent and therapeutically equivalent to the reference listed drug (RLD), Symtuza Tablets, 800 mg/150 mg/200 mg/10 mg of Janssen Products, LP. Lupin is the ...

The company's product has been found to be therapeutically equivalent to the reference listed drug Symtuza tablets, 800 mg/150 mg/200 mg/10 mg of Janssen Products, LP, it added. Lupin is the exclusive ...

Indian pharmaceutical company Lupin announced on Monday that it has secured approval from the US Food and Drug Administration (USFDA) to introduce a generic HIV medication to the American market. The ...

The stock had hit a 52-week high of Rs 2,403.45 on January 2, 2025. Lupin specialises in pharmaceutical products, including branded and generic formulations, complex generics, biotechnology products, ...

Darunavir, Cobicistat, Emtricitabine, and Tenofovir Alafenamide tablets are therapeutic equivalents of Symtuza Tablets 800 mg/150 mg/200 mg/10 mg brand of Janssen Products, LP. According to IQVIA ...

This ANDA has been found to be bioequivalent and therapeutically equivalent to the reference listed drug (RLD), Symtuza tablets, 800 mg/150 mg/200 mg/10 mg of Janssen Products, LP. Lupin is the ...

Lupin receives tentative USFDA approval for ... which the company says is therapeutically equivalent to Janssen Products’ reference drug, Symtuza. According to IQVIA data for the period ending ...

Lupin has received approval from the Food and Drug Administration for ipratropium bromide nasal solution (nasal spray), 0.06%, which is a generic of Boehringer Ingelheim's Atrovent Nasal Spray, 0.06%.

The company's product has been found to be therapeutically equivalent to the reference listed drug Symtuza tablets, 800 mg/150 mg/200 mg/10 mg of Janssen Products, LP, it added. Lupin is the exclusive ...

The world is currently grappling with what US President Trump will do or undo on the tariffs front. And markets will have to deal with this issue till the politics of one-upmanship is settled. As an ...

Drug maker Lupin Ltd confirmed on Tuesday that it has received tentative approval from the ... The company’s product has been found to be therapeutically equivalent to the reference listed drug ...